Kazansky A V, Rosen J M
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030-3498, USA.
Cell Growth Differ. 2001 Jan;12(1):1-7.
Previously, we reported that whereas both signal transducers and activators of transcription (STAT) 5A and STAT5B can be activated with respect to tyrosine phosphorylation and DNA binding potential by Src kinase, only STAT5B was translocated to the nucleus, where it presumably activates unique downstream responses. To help elucidate the functional consequences of STAT5B activation by v-src, the properties of stably transfected NIH-3T3 cells containing both an intact and a dominant negative, COOH-terminal-truncated isoform of STAT5B were investigated. STAT5B enhanced the transforming potential of v-Src as reflected by both an increase in focus formation and growth in soft agar. STAT5B also enhanced v-Src-induced cell cycle progression and cell motility in NIH-3T3 cells. Furthermore, the dominant negative, COOH-terminal-truncated isoform of STAT5B was able to partially suppress v-Src-mediated cell transformation. These results support the hypothesis that STAT5B may enhance Src/Abl-induced tumorigenesis. Accordingly, the equilibrium between STAT5B and STAT5A and their naturally occurring truncated forms may therefore play a key role in the etiology of certain cancers.
此前,我们报道过,虽然信号转导子和转录激活子(STAT)5A和STAT5B均可被Src激酶激活酪氨酸磷酸化及DNA结合潜能,但只有STAT5B会转位至细胞核,在那里它可能激活独特的下游反应。为了帮助阐明v-src激活STAT5B的功能后果,我们研究了稳定转染的NIH-3T3细胞的特性,这些细胞同时含有完整的和显性负性的、COOH末端截短的STAT5B异构体。STAT5B增强了v-Src的转化潜能,这体现在集落形成增加和软琼脂中生长能力增强两方面。STAT5B还增强了v-Src诱导的NIH-3T3细胞的细胞周期进程和细胞运动性。此外,显性负性的、COOH末端截短的STAT5B异构体能够部分抑制v-Src介导的细胞转化。这些结果支持了STAT5B可能增强Src/Abl诱导的肿瘤发生这一假说。因此,STAT5B与STAT5A及其天然存在的截短形式之间的平衡可能在某些癌症的病因学中起关键作用。